Showing results (141-150 of 229) with videos related to

Sort By:
Pageof 23
Familial Cancer|October 9, 2020
Discordant DNA mismatch repair protein status between synchronous or metachronous gastrointestinal carcinomas: frequency, patterns, and molecular etiologiesMonika Vyas, Canan Firat, Jaclyn F Hechtman, et al.
JNCI Cancer Spectrum|May 24, 2019
Contemporary Validation of a Nomogram Predicting Colon Cancer Recurrence, Revealing All-Stage Improved OutcomesTsuyoshi Konishi, Yoshifumi Shimada, Meier Hsu, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in <i>BRCA1/2</i> CarriersGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Cancer|October 7, 2015
Identification of germline genetic mutations in patients with pancreatic cancerErin E Salo-Mullen, Eileen M O'Reilly, David P Kelsen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 21, 2026
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in Women with Pathogenic BRCA1/2 VariantsGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Journal of Genetic Counseling|October 14, 2016
Educational and Psychosocial Support Needs in Lynch Syndrome: Implementation and Assessment of an Educational Workshop and Support GroupMarina J Corines, Jada G Hamilton, Emily Glogowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2020
Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline <i>BRCA/PALB2</i> MutationEileen M O'Reilly, Jonathan W Lee, Mark Zalupski, et al.
European Journal of Cancer (Oxford, England : 1990)|December 11, 2017
Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinomaMaeve A Lowery, David P Kelsen, Marinela Capanu, et al.
Nature Genetics|July 18, 2018
Genome doubling shapes the evolution and prognosis of advanced cancersCraig M Bielski, Ahmet Zehir, Alexander V Penson, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 14, 2021
Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancerJada G Hamilton, Heather Symecko, Kelsey Spielman, et al.
Pageof 23